Researchers at UT Southwestern Medical Heart led a research revealed in JAMA Community Open which discovered that particular chemotherapies are related to an elevated long-term...
The FDA has accepted Rybrevant Faspro (amivantamab and hyaluronidase-lpuj) as the primary and solely subcutaneous, chemo-free therapy for sufferers with EGFR-mutated non-small cell lung most...
Lively Biotech has obtained optimistic suggestions from regulators on a protocol modification to its ongoing proof-of-concept scientific trial evaluating tasquinimod in sufferers with myelofibrosis, a...
Amongst sufferers with estrogen receptor (ER)-positive, HER2-negative superior breast most cancers beforehand handled with a CDK4/6 inhibitor, the mix or oral selective...
Lengthy-term follow-up of the BFR14 trial confirmed that Gleevec (imatinib) stays efficient in superior gastrointestinal stromal tumors (GIST), with sufferers reaching full...
The mixture of Lenvima (lenvatinib) and Keytruda (pembrolizumab) with chemotherapy didn't assist sufferers with metastatic esophageal squamous cell carcinoma stay longer in...
Amongst sufferers with muscle-invasive bladder most cancers, the addition of perioperative Imfinzi (durvalumab), which means it's administered earlier than and after surgical...
Amongst sufferers with gastric/gastroesophageal junction (G/GEJ) adenocarcinoma that's resectable, or detachable by surgical procedure the mixture of the anti-PD-L1 monoclonal antibody Imfinzi...
